M. Jeschke

发表

Discrimination Between Silicone Oil Droplets and Protein Aggregates in Biopharmaceuticals: A Novel Multiparametric Image Filter for Sub-visible Particles in Microflow Imaging Analysis

A. Koulov, Verena Rombach-Riegraf, K. Egodage, 2011, Pharmaceutical Research.

NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells.

D. Taverna, B. Marte, N. Hynes, 1995, Oncogene.

Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cells.

M. Campiglio, S. Ménard, B. Groner, 1996, British Journal of Cancer.

Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.

D. Taverna, B. Groner, Y. Yarden, 1995, Molecular endocrinology.

Targeted inhibition of tumor‐cell growth by recombinant heregulin‐toxin fusion proteins

B. Groner, W. Wels, M. Jeschke, 1995, International journal of cancer.

Fluoroaluminate stimulates phosphorylation of p130 Cas and Fak and increases attachment and spreading of preosteoblastic MC3T3-E1 cells.

M. Šuša, J. van Oostrum, H. Voshol, 2002, Bone.

Expression of Src Family Kinases and Their Putative Substrates in the Human Preosteoclastic Cell Line FLG 29.1

M. Šuša, M. Brandi, M. Jeschke, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Biotechnological and gene therapeutic strategies in cancer treatment.

B. Groner, N. Hynes, W. Wels, 1995, Gene.

Intra‐tumoral application of a heregulin‐exotoxin‐A fusion protein causes rapid tumor regression without adverse systemic or local effects

B. Groner, M. Mihatsch, W. Wels, 1997, International journal of cancer.

Recombinant Fusion Toxins Targeted to Members of the ErbB Family of Receptor Tyrosine Kinases

B. Groner, N. Hynes, W. Wels, 1997 .

Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry

R. Chawla, M. Perales, S. Nikiforow, 2019, Blood.

Determination of the Origin of Charge Heterogeneity in a Murine Monoclonal Antibody

Margit Jeschke, S. Lunte, Melissa Perkins, 2000, Pharmaceutical Research.

Fluoroaluminate induces pertussis toxin-sensitive protein phosphorylation: differences in MC3T3-E1 osteoblastic and NIH3T3 fibroblastic cells.

M. Šuša, D. Rohner, M. Jeschke, 1997, Biochemical and biophysical research communications.

Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.

B. Groner, B. Schnierle, M. Jeschke, 1996, Gene therapy.

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

Wei Chen, B. Groner, R. Livingston, 1994, Cancer research.

Fluoroaluminate Induces Activation and Association of Src and Pyk2 Tyrosine Kinases in Osteoblastic MC3T3-E1 Cells*

M. Šuša, M. Jeschke, G. Standke, 1998, The Journal of Biological Chemistry.

Laminin activates thep185HER2 oncoprotein andmediates growth inhibition ofbreast carcinoma cells

R. Bufalino, M. Jeschke, 1996 .

A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo.

M. Šuša, J. Green, J. Feyen, 1999, Bone.

Discrimination Between Silicone Oil Droplets and Protein Aggregates in Biopharmaceuticals: A Novel Multiparametric Image Filter for Sub-visible Particles in Microflow Imaging Analysis

A. Koulov, Verena Rombach-Riegraf, K. Egodage, 2012, Pharmaceutical Research.

Size fractionation of microscopic protein aggregates using a preparative fluorescence-activated cell sorter.

F. Raulf, Verena Rombach-Riegraf, K. Egodage, 2013, Journal of pharmaceutical sciences.